[Federal Register Volume 68, Number 15 (Thursday, January 23, 2003)]
[Notices]
[Pages 3255-3260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-1434]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 03007]


Childhood Lead Poisoning Prevention Programs (CLPPP); Notice of 
Availability of Funds

A. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301(a), 317A and 317B of 
the Public Health Service Act [42 U.S.C. 241(a), 247b-1, and 247b-3], 
as amended by the Children's Health Act of 2000. Program regulations 
are set forth in Title 42, Code of Federal Regulations, Part 51b to 
State and local health departments. The Catalog of Federal Domestic 
Assistance number is 93.197.

B. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2003 funds for a cooperative agreement 
program for Childhood Lead Poisoning Prevention Programs (CLPPP). This 
program addresses the ``Healthy People 2010'' environmental health 
objective to eliminate elevated blood lead levels in children. (found 
at: http://www.health.gov/healthypeople/)
    The purpose of the program is to assist state and local partners in 
building capacity to eliminate childhood lead poisoning as a major 
public health problem. The focus of the program is children under the 
age of six. Special emphasis will be placed on children under the age 
of 3 who have elevated blood lead levels. The program will also address 
families with children under the age of six who do not yet have 
elevated blood lead levels.
    Measurable outcomes of the program will be in alignment with the 
following

[[Page 3256]]

performance goal of the National Center for Environmental Health 
(NCEH): reduce the burden of lead poisoning in children.
    A glossary of scientific and technical terms can be found in 
Appendix I. A background statement about the CDC program can be found 
in Appendix II. All appendices and attachments are posted with this 
announcement on the CDC Web site.

C. Eligible Applicants

    Applications may be submitted by state health departments, their 
bona fide agents, and the health departments of the following five 
local jurisdictions that have the highest estimated number of children 
with elevated blood lead levels: New York, NY; Chicago, IL; Detroit, 
MI; Los Angeles County, CA, and Philadelphia, PA, or their bona fide 
agents. (See Appendices III and IV for more information on city blood 
lead levels.) Applications may also be submitted by the health 
departments or other official organizational authorities of the 
District of Columbia, the Commonwealth of Puerto Rico, the Virgin 
Islands, the Commonwealth of the Northern Mariana Islands, American 
Samoa, Guam, the Federated States of Micronesia, the Republic of the 
Marshall Islands, the Republic of Palau, and federally recognized 
Indian tribal governments. Competition is limited to these entities by 
authorizing legislation.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501c(4) of the Internal Revenue 
Code that engages in lobbying activities is not eligible to receive 
Federal funds constituting an award, grant or loan.

D. Funding

Availability of Funds
    Approximately $31,000,000 is available in FY 2003 to fund 
approximately 40 awards. It is expected that the average award will be 
$775,000, ranging from $75,000 to $1,700,000. It is expected that the 
awards will begin on or about July 1, 2003 and will be made for a 12-
month budget period within a project period of up to three years. 
Funding estimates may change, depending on availability of funds.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.
Use of Funds
    Funds must be used for the following program activities: (a) The 
writing, implementation and evaluation of a jurisdiction-wide childhood 
lead poisoning elimination plan; (b) the writing, implementation, and 
evaluation of screening plans to target resources to children at the 
highest risk for lead poisoning; (c) a jurisdiction-wide childhood lead 
surveillance program, with an analysis plan for collected data; (d) 
primary prevention activities for pregnant women and/or families with 
children at high risk for lead poisoning; (e) an assurance plan for 
timely and appropriate case management of children with elevated blood 
lead levels; (f) demonstration of strategic partnering with community 
organizations and with other state/local agencies involved in 
environmental and child health activities; (g) substantial coordination 
with organizations and agencies involved in lead-based paint hazard 
reduction activities and development of protective policy; and (h) 
evaluation of programmatic impact on childhood lead poisoning within 
the applicant's jurisdiction.
    Funds may not be expended for medical care and treatment, or for 
environmental remediation of sources of lead exposure. However, the 
applicant must provide a plan to ensure that these program activities 
are carried out and demonstrate their program's appropriate involvement 
with medical care, treatment and remediation efforts.
    Not more than 10 percent (exclusive of direct assistance) of any 
cooperative agreement or contract (sub-grantee or consultant) funded 
through the cooperative agreement may be obligated for administrative 
costs. This 10 percent limitation is in lieu of, and replaces, the 
indirect cost rate.
Recipient Financial Participation
    Matching funds are not required for this program. Applicant must 
assure that income earned by the CLPPP will be returned to the program 
to support lead poisoning prevention activities.
Funding Preference
    CDC will give funding preference to state programs that have 
significant estimated numbers of children with elevated blood lead 
levels, and that direct federal funds to localities with high 
concentrations of children at risk for childhood lead poisoning. CDC 
will also give funding preference to the five local jurisdictions with 
the highest estimated number of children with elevated blood lead 
levels. Guidance is available in Appendices III and IV, CDC's estimate 
of children under age six with elevated blood lead levels by city and 
state, respectively.

E. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities in 1. Recipient 
Activities, and CDC will be responsible for the activities listed in 2. 
CDC Activities.
1. Recipient Activities
a. Childhood Lead Poisoning Elimination Plan
    [sbull] Programs must establish an advisory workgroup or committee 
(or expand the scope of its current advisory group) to publish and 
implement a statewide or jurisdiction-wide childhood lead poisoning 
elimination plan. The group should also serve to monitor the progress 
of the elimination plan, and to leverage resources and enhance 
cooperative efforts towards this goal.

--This committee/workgroup should, at a minimum, include 
representatives from the Health Department, Housing and Urban 
Development (HUD) and/or the housing department, Environmental 
Protection Agency (EPA) and/or the state or local environmental 
regulatory agency, and the state Medicaid agency.
--Member representatives should have sufficient authority to support an 
inter-agency committee/workgroup, and to commit staff and resources to 
the elimination work plan.
--By the end of year one, programs must write a statewide or 
jurisdiction-wide strategic plan to eliminate childhood lead poisoning 
as a major public health problem by 2010. At a minimum, the plan must 
include the following elements:

Mission Statement
Purpose and Background on Lead Poisoning Prevalence
Goals, Objectives and Activities
Evaluation Plan

    Further guidance on developing the elimination plan and forming the 
advisory workgroup or committee is located in Appendix V, ``Guidance 
for Developing a Jurisdiction-wide Strategic Plan for the Elimination 
of Childhood Lead Poisoning.''
b. Targeted Screening Plan
    [sbull] Programs will write, implement and evaluate a jurisdiction-
wide screening plan to target resources to impact the largest numbers 
of children at high risk for lead poisoning. Particular emphasis should 
be placed on children under three years of age and at high risk. 
Applicants should refer to the CDC publication, ``Screening Young 
Children for Lead Poisoning: Guidance for State

[[Page 3257]]

and Local Public Health Officials'' (found at: http://www.cdc.gov/nceh/lead/guide/guide97.htm) and to Appendices III and IV, the CDC estimates 
of children under six with elevated blood lead levels by city and 
state.
    [sbull] Programs with an approved jurisdiction-wide screening plan 
already in place should include a copy as an appendix to their 
application. Application work plans must include goals and objectives 
describing screening performance measures and plans for periodic 
evaluation and improvement of the screening plan.
    [sbull] Programs without a screening plan will provide work plan 
objectives for publishing and implementing a screening plan within one 
year of award.
    [sbull] The screening plan should address uses of health education 
and communication to the targeted screening population. Additionally, 
the screening plan should address the education and communication of 
screening recommendations and childhood lead poisoning prevention 
efforts to health care providers.
    [sbull] The screening plan will be reviewed and updated at least 
annually, and resubmitted to the assigned CDC Project Officer for 
review and comment.
c. Surveillance
    [sbull] Programs must maintain and/or enhance a statewide or 
jurisdiction-wide childhood lead surveillance system to meet the 
criteria in Appendix VI (Elements Of Developing And Maintaining A 
Surveillance System). If programs do not have an existing surveillance 
system that meets these criteria, the application work plan should 
include objectives demonstrating how the surveillance system will be 
designed and implemented to meet the criteria within the first year of 
the project period. The program should also describe the 
implementation, or planned implementation, of regulations within the 
state or jurisdiction requiring the reporting of all blood lead results 
for children less than 72 months of age.
d. Primary Prevention
    [sbull] Programs must conduct childhood lead poisoning primary 
prevention activities for families at high risk for lead poisoning to 
include those who live in housing built prior to 1978. The program 
should focus activities on pregnant women and/or families with young 
children at high-risk for lead poisoning exposure. The program should 
consider, but is not limited to, the examples of primary prevention 
activities in Appendix VII.
    [sbull] Educational material and media campaigns may be used to 
support primary prevention activities.
    [sbull] Primary prevention activities must be regularly evaluated 
for effectiveness in reducing the childhood lead burden in higher risk 
communities and/or populations. Evaluation of primary prevention 
activities should not include human subjects research.
e. Case Management of Children With Elevated Blood Lead Levels
    [sbull] Provide a written case management plan consistent with 
published state and local guidelines, or the recommendations from the 
National Advisory Committee on Childhood Lead Poisoning Prevention, 
``Managing Elevated Blood Lead Levels Among Young Children'', (found 
at: http://cdc.gov/nceh/lead/CaseManagement/caseManage_main.htm), 
within the first six months of the project period.
    [sbull] Establish specific application work plan goals and 
objectives for reducing over-all morbidity (in children identified with 
elevated blood lead levels) by tracking and assuring appropriate and 
timely coordination of case management activities in accordance with 
established protocols.
    [sbull] Implement targeted health education and communication 
activities to support improvements in timely and appropriate care.
    [sbull] Case management will be evaluated at least quarterly using 
surveillance and case management data. At a minimum, the program should 
review the time frames for (a) initiating and completing case 
management services, including the first home visit; (b) a written care 
plan for each case; (c) the reduction of blood lead level rates; and 
(d) the rates of case closure by category (e.g., medical or 
administrative closure.)
f. Strategic Partnerships
    [sbull] The program should demonstrate the development of strategic 
partnerships with community organizations, health-care providers, and 
other governmental and non-governmental organizations conducting 
childhood lead poisoning prevention activities and/or developing 
protective policies, as well as other programs focused on children 
likely to be at high risk for lead poisoning (e.g., Women, Infant and 
Children Program (WIC), Immunizations, Asthma Control, Head Start and 
Healthy Start).
    [sbull] Strategic partnerships should be demonstrated by the 
inclusion of letters of support, memoranda of understanding, and/or 
contracts in the application.
    [sbull] Guidance for working with and within communities can be 
found in the CDC document, ``Principles of Community Engagement'' 
(found at: http://www.cdc.gov/phppo/pce/index.htm).
g. Activities With Organizations and Agencies Engaged in Lead Hazard 
Reduction and Development of Protective Policy
    [sbull] The applicant should demonstrate coordination of, or plans 
to coordinate activities with those organizations engaged in lead 
remediation and abatement (e.g., housing agencies, HUD funded lead 
hazard reduction grantees, and banking, real estate, and insurance 
interests).
    [sbull] Planned or ongoing activities should include the education 
and communication of childhood lead poisoning prevention efforts and 
protective policies to target audiences (e.g., landlords, homeowners, 
legislative officials).
    [sbull] Planned or ongoing coordination activities should be 
demonstrated by the inclusion of letters of support, memoranda of 
understanding, and/or contracts in the application.
h. Evaluation Plan
    The evaluation plan should address the effectiveness of the CLPPP 
by program area, as well as the overall impact of the program in 
reducing and preventing childhood lead poisoning within the 
jurisdiction. Evaluation should take place at least annually.
    The evaluation plan should: (1) Address the program as a whole; (2) 
specifically address each program goal; (3) have measurable, achievable 
and time-phased objectives; (4) focus on programmatic outcome/impact on 
eliminating childhood lead poisoning as a public health problem; (5) 
include the name and qualifications of the person responsible for 
conducting the evaluation; (6) specify how often evaluation will be 
conducted; and (7) discuss how the results of the evaluation will be 
built into improving each of the program components.
    The same terms and definitions used for the work plan should be 
used in the evaluation plan (see Appendix VIII).
    Guidance related to the components of an effective evaluation plan 
can be found in the CDC document ``Framework for Program Evaluation in 
Public Health'' (found at: http://www.cdc.gov/eval/framework.htm). 
Additional guidance can be found at the ``CDC Evaluation Working Group 
Web Site'' (http://www.cdc.gov/eval/).
    The program should specify whether or not identifiable information 
will be

[[Page 3258]]

included in evaluation-related analysis. Use of identifiable 
information may require Institutional Review Board (IRB) approval.
2. CDC Activities
    a. Provide technical assistance and scientific consultation on 
program development, implementation, and operational issues.
    b. Provide technical assistance and scientific consultation 
regarding the development and implementation of all surveillance 
activities, including data collection methods and analysis of data. 
Assist with improving data linkages with federally funded, means-tested 
public benefit programs (WIC, Head Start, etc.)
    c. Assist in the development of elimination plans and targeted 
screening plans by providing technical assistance and training on tools 
such as Geographic Information Systems (GIS) software.
    d. Assist with interpretation of individual state surveillance 
data.
    e. Review draft work plans and provide guidance.
    f. Review draft program evaluation criteria and presentation 
formats, and provide guidance.

F. Content

Applications
    The Program Announcement title and number must appear in the 
application. Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan. The narrative should be no more than 35 pages, double-spaced, 
printed on one side, with one-inch margins, and unreduced 12-point 
font.
    The narrative should consist of, at a minimum, a work plan, an 
evaluation plan, and budget. The work plan must include project goals 
and first year objectives for each of the program areas listed under 
Program Requirements, Recipient Activities in this announcement 
(paragraph E, 1., a.-h.), The applicant should also include a tentative 
work plan and timetable for the remaining years of the proposed 
project.
    The applicant should provide a detailed work plan that describes 
how the overall CLPPP and each of the eight program areas described 
within the application will be conducted. See Appendix VIII (Work Plan) 
for guidance.
    Pursuant to section 317A of the Public Health Service Act (42 
U.S.C. 247b-1), as amended by Section 303 of the ``Preventive Health 
Amendments of 1992'' (Pub. L. 102-531), applicants must meet the 
following requirements: For CLPPP services that are Medicaid-
reimbursable in the applicant's state:
    [sbull] Applicants directly providing these services must be 
enrolled with their state Medicaid agency as a Medicaid provider.
    [sbull] Providers entering into agreements with the applicant to 
provide such services must be enrolled with their State Medicaid agency 
as a Medicaid provider. An exception to this requirement will be made 
for providers whose services are provided free of charge, and who 
accept no reimbursement from any third-party payer. Providers accepting 
voluntary donations may still be exempted from this requirement.
    To satisfy this program requirement, applicants must submit a copy 
of a Medicaid provider certificate or statement as proof that this 
requirement will be met. Failure to include this information will 
result in the application being returned. This information should be 
placed immediately behind the budget and budget justification pages.

G. Submission and Deadline

Application Forms
    Submit the signed original and two copies of PHS 5161-1 (OMB Number 
0920-0428). Forms are available at the following Internet address: 
http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) at (770) 488-2700. Application forms can be mailed to you.
    Application forms must be submitted in the following order:

Cover Letter
Table of Contents
Application
Narrative with Work Plan and Evaluation Plan
Budget Information Form
Budget Justification
Medicaid Provider Certificate/Statement of Proof
Checklist
Assurances
Certifications
Disclosure Forms
Submission Date, Time, and Address
    The application must be received by 4 p.m. Eastern Time, March 24, 
2003. Submit the application to: Technical Information Management--
PA03007, Procurement and Grants Office, Centers for Disease 
Control and Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 
30341-4146.
    Applications may not be submitted electronically.
CDC Acknowledgment of Application Receipt
    A postcard will be mailed to you by PGO-TIM, notifying you that CDC 
has received your application.
Deadline
    Applications shall be considered as meeting the deadline if they 
are received before 4 p.m. Eastern Time on the deadline date. Any 
applicant who sends their application by the United States Postal 
Service or commercial delivery services must ensure that the carrier 
will be able to guarantee delivery of the application by the closing 
date and time. If an application is received after closing due to (1) 
carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, CDC will, upon receipt of proper 
documentation, consider the application as having been received by the 
deadline.
    Any application that does not meet the above criteria will not be 
eligible for competition, and will be discarded. The applicant will be 
notified of their failure to meet submission requirements.

H. Evaluation Criteria

Application
    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goal stated in the purpose section of this 
announcement. Measures must be objective and quantitative and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    An independent review group appointed by CDC will evaluate each 
application against the following criteria:
1. Need (25 points)
    The announcement is focused on the elimination of childhood lead 
poisoning as a major public health problem. Therefore, the assessment 
of need within the applicant's jurisdiction should include focus on 
communities and populations where there is significant evidence of high 
numbers of children under six years old who are at

[[Page 3259]]

high risk for lead poisoning. The applicant should describe the extent 
of the problem in the highest risk areas as determined by evidence. The 
evidence could include surveillance data for calendar years 1995-2000, 
detailing the number of children 0-36 months and 37-72 months with 
confirmed blood lead levels greater than or equal to 10 micrograms per 
deciliter (ug/dl) (using the CSTE definition of confirmed cases; see 
Appendix II.) The applicant may also consider other sources such as 
Appendices III and IV of this announcement (Estimated Number of 
children with Elevated Blood Lead Levels (EBLL) by City and State, 
respectively), Medicaid data, and housing-related data to support their 
description of need.
2. Capacity To Eliminate Childhood Lead Poisoning as a Public Health 
Problem (20 points)
    [sbull] Provide evidence that the applicant has published and 
implemented a jurisdiction-wide screening plan that targets screening 
resources to children at highest risk. A copy of the plan should be 
included with the application. Or, describe plans to implement a 
screening plan in the first year of the proposed project period.
    [sbull] The implementation, or planned implementation, of 
regulations within the state or jurisdiction requiring the reporting of 
all blood lead results for children under 72 months of age.
    [sbull] The extent to which the applicant describes their 
jurisdictional childhood blood lead surveillance system in the 
following areas:

--Case management and program monitoring capabilities.
--The ability to determine screening and EBLL rates among specific 
high-risk populations, particularly Medicaid eligible children.
--The percentage of laboratory blood lead test results reported 
electronically to the state and/or local health department; and plans 
to increase the percentage of lab tests electronically imported to the 
surveillance database.
--Current or planned use of electronic transfer of data from 
laboratories, WIC, immunizations, birth certificates, and between local 
and state health departments.
--The ability to identify and assure reporting from private labs and 
portable blood lead analyzers.
--Plans for data analysis and dissemination of findings, as well as an 
evaluation of the surveillance system using CDC guidelines.

    [sbull] Extent to which the applicant demonstrates use of 
surveillance data to target lead poisoning prevention activities (e.g., 
screening, environmental investigations, lead hazard reduction, primary 
prevention, and implementation of protective policies) to the 
populations at highest risk in their jurisdiction.
    [sbull] Extent to which strategic partnerships, programs, and 
activities within the jurisdiction have been implemented to eliminate 
childhood lead poisoning from the community.
    [sbull] Extent to which applicant has committed their resources 
(personnel and financial) to the elimination of childhood lead 
poisoning.
3. Goals and Objectives (20 points)
    [sbull] Extent to which the goals relate to the project purpose of 
childhood lead poisoning elimination, screening, surveillance, primary 
prevention, case-management, strategic community partnerships, and 
activities coordinated with agencies involved in lead hazard reduction 
activities and policies.
    [sbull] Objectives must be time-phased, achievable, measurable, and 
must be provided for the first budget year.
    [sbull] The submission of a clearly written work plan that includes 
project goals; supporting first year objectives that are relevant, 
specific, measurable, achievable, and time-phased; activities leading 
to the completion of objectives; a timetable for completing the 
proposed activities; identification of the program staff responsible 
for accomplishing each objective; and process evaluation measures for 
each proposed objective.
    [sbull] The inclusion of a tentative work plan and timetable for 
the remaining years of the proposed project.
4. Jurisdiction-Wide Planning and Collaboration (15 points)
    [sbull] Applicant's ability to involve strategic partners in the 
publication and implementation of a targeted screening plan, the and 
implementation of strategies to eliminate childhood lead poisoning.
    [sbull] Extent to which surveillance and program data are utilized 
to produce jurisdiction-wide screening recommendations, with specific 
attention given to the Medicaid population, as required in the 
Children's Health Act of 2000.
    [sbull] Demonstrated strategic partnerships through letters of 
support, memoranda of understanding, contracts, or other documented 
evidence of relationships. Examples of key partners include Medicaid 
agencies, child health-care providers and provider groups, managed-care 
organizations, insurers, community-based organizations, housing 
agencies (especially HUD funded lead hazard reduction programs), and 
banking, real estate, and property-owner interests.
5. Program Evaluation (15 points)
    [sbull] Description of a systematic assessment of the operations 
and outcomes of the program as a means of contributing to the 
elimination of childhood lead poisoning.
    [sbull] Effective strategies and approaches to monitor and improve 
the quality, effectiveness, and efficiency of the program.
    [sbull] Description of how evaluation findings will be used to 
assess changes in public policy and measure the program's effectiveness 
of strategic partnering activities.
    [sbull] Description of how the program will document progress made 
in childhood lead poisoning prevention.
6. Project Management and Staff (5 points)
    [sbull] Documentation of the ability to develop and carry out 
activities described as recipient activities in the program 
requirements section of this announcement. This should include a 
description of the proposed health department staff roles, their 
specific responsibilities, and their level of effort and time.
    [sbull] Inclusion of assurances that vacant positions will be 
filled within a reasonable time after receiving funding.
    [sbull] Inclusion of a plan to provide training and technical 
assistance to health department personnel and consultation to strategic 
partners.
7. Budget Justification (reviewed, not scored)
    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of funds. The applicant should 
include costs for up to two people to travel to Atlanta, GA (three-
overnight stays), to attend a Program Partners' meeting in 2003, and 
for one person to travel to Atlanta, GA (three-overnight stays), to 
attend the 6th National Environmental Health Conference December 3-5, 
2003.
8. Performance Goals (reviewed, not scored)
    The extent to which the application is aligned with the NCEH focus 
of environmental health, specifically, helping states reduce the burden 
of lead poisoning in children.

I. Other Requirements

Technical Reporting Requirements
    Provide CDC with the original plus two copies of:

[[Page 3260]]

    1. Quarterly data progress reports. These quarterly reports are 
required by the Office of Management and Budget (OMB) authorizing 
legislation (OMB Form 0920-0282.) The reports are due 30 days after the 
end of each quarter.
    2. An interim progress narrative report, due no less than 90 days 
before the end of the budget period. This progress report will serve as 
your non-competing continuation application, and must contain the 
following elements:
    a. Progress on Current Budget Period Objectives and Activities.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Proposed Program Objectives and Activities.
    d. Detailed Line-Item Budget and Justification.
    3. Calendar-year surveillance data, submitted annually in the 
approved OMB format, no later than April 30. In addition, a written 
surveillance summary must be disseminated to state and local public 
health officials, policy makers, the CDC project officer, and others.
    4. Financial Status Reports, due within 90 days of the end of the 
budget period.
    5. Final financial reports and performance reports, due within 90 
days after the end of the project period.
    6. Projects that involve the collection of information from 10 or 
more individuals, and are funded by a cooperative agreement will be 
subject to review by OMB under the Paperwork Reduction Act. Data 
collection initiated under this cooperative agreement program has been 
approved by OMB under OMB number 0920-0337, ``National Childhood Blood 
Lead Surveillance System'', Expiration Date: 6/30/2004.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
Additional Requirements
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I of the 
program announcement as posted on the CDC Web site.

AR-9, Paperwork Reduction Act Requirements
AR-10, Smoke-Free Workplace Requirements
AR-11, Healthy People 2010
AR-12, Lobbying Restrictions
AR-21, Small, Minority & Women-Owned Businesses

    Executive Order 12372 does not apply to this program.

J. Where To Obtain Additional Information

    Two telephone conference calls for application technical assistance 
will be held during the application period. For further information, 
please contact Rob Henry at (770) 488-4024. This, and other CDC 
announcements, necessary applications, and associated forms can be 
found on the CDC home page Internet address: http://www.cdc.gov. Click 
on ``Funding'', then ``Grants and Cooperative Agreements.''

For general questions regarding this announcement, contact: Technical 
Information Management, CDC Procurement and Grants Office, 2920 
Brandywine Road, Room 3000, Atlanta, GA 30341-4146, Telephone: (770) 
488-2700.
For business management and budget assistance, contact: Mildred Garner, 
Grants Management Officer, CDC Procurement and Grants Office, 2920 
Brandywine Road, Room 3000, Atlanta, GA 30341-4146, Telephone: (770) 
488-2745, E-mail address: [email protected].
For business management and budget assistance in the territories, 
contact: Charlotte Flitcraft, Grants Management Officer, CDC 
Procurement and Grants Office, 2020 Brandywine Rd., Room 3000, Atlanta, 
GA 30319, Telephone: 770-488-2632, E-mail address: [email protected].
For program technical assistance, contact: Rob Henry, Acting Team 
Leader, Program Services Section, Lead Poisoning Prevention Branch, 
Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, MS E-
25, Atlanta, GA 30333, Telephone: (770) 488-4024, E-mail address: 
[email protected].

    Dated: December 31, 2002.
Sandra R. Manning,
CGFM, Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-1434 Filed 1-22-03; 8:45 am]
BILLING CODE 4163-18-P